Geoffrey Falkson
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies 46
- Oncology top 0.5%
- Cancer Treatment and Pharmacology 84
- Colorectal Cancer Treatments and Studies 16
-
- Lung Cancer Treatments and Mutations 22
-
- Lymphoma Diagnosis and Treatment 21
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis 17
-
- Estrogen and related hormone effects 19
-
- Cancer therapeutics and mechanisms 16
Geoffrey Falkson
255 papers receiving 6.3k citations
Peers
Comparison fields: 5 of 132
- Cancer Research 2.0k
- Oncology 3.4k
- Pulmonary and Respiratory Medicine 2.0k
- Pathology and Forensic Medicine 1.1k
- Hepatology 437
Countries citing papers authored by Geoffrey Falkson
This map shows the geographic impact of Geoffrey Falkson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoffrey Falkson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoffrey Falkson more than expected).
Fields of papers citing papers by Geoffrey Falkson
This network shows the impact of papers produced by Geoffrey Falkson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoffrey Falkson. The network helps show where Geoffrey Falkson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Geoffrey Falkson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 1 | |
| 2 | 1998 | 13 | |
| 3 | 1996 | 14 | |
| 4 | 1993 | 12 | |
| 5 | 1992 | 27 | |
| 6 | 1992 | 5 | |
| 7 | 1992 | 21 | |
| 8 | 1990 | 39 | |
| 9 | 1990 | 42 | |
| 10 | 1988 | 4 | |
| 11 | 1988 | 3 | |
| 12 | 1988 | 11 | |
| 13 | 1985 | 3 | |
| 14 | 1980 | 45 | |
| 15 | Acute leukemia as a complication of long-term treatment of advanced breast cancer. | 1979 | 26 |
| 16 | Hepatitis B surface antigen and primary liver cancer. | 1978 | 6 |
| 17 | 1971 | 23 | |
| 18 | 1970 | 60 | |
| 19 | Combined cancer chemotherapy and radiotherapy in the treatment of human cancer | 1965 | 1 |
| 20 | EXPERIENCE WITH CHEMOTHERAPY OF CANCER AT THE UNIVERSITY OF PRETORIA. | 1964 | 4 |
About Geoffrey Falkson
Geoffrey Falkson is a scholar working on Oncology, Cancer Research, Hepatology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 264 papers that have together received 6.8k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (84 papers), Breast Cancer Treatment Studies (46 papers), Lung Cancer Treatments and Mutations (22 papers), Lymphoma Diagnosis and Treatment (21 papers), Estrogen and related hormone effects (19 papers), Hepatocellular Carcinoma Treatment and Prognosis (17 papers), Colorectal Cancer Treatments and Studies (16 papers) and Cancer therapeutics and mechanisms (16 papers). The work is most often cited by research in Cancer Research (2.0k citations), Oncology (3.4k citations), Pulmonary and Respiratory Medicine (2.0k citations), Pathology and Forensic Medicine (1.1k citations) and Hepatology (437 citations). Geoffrey Falkson has collaborated with scholars based in South Africa, United States and Switzerland. Frequent co-authors include H. C. Falkson, Douglass C. Tormey, Carla I. Falkson, W. R. Bezwoda, L. Goedhals, D C Tormey, Charles G. Moertel, Rebecca Gelman, John Macintyre and E. Schulz. Their work appears in journals such as Cancer, Journal of Clinical Oncology, Investigational New Drugs, Oncology and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.